These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2049034)

  • 1. T-cell reactivity to purified lipophosphoglycan from Leishmania major: a model for analysis of the cellular immune response to microbial carbohydrates.
    Moll H; Röllinghoff M
    Behring Inst Mitt; 1991 Feb; (88):161-9. PubMed ID: 2049034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of T-cell recognition in mice of a purified lipophosphoglycan from Leishmania major.
    Moll H; Mitchell GF; McConville MJ; Handman E
    Infect Immun; 1989 Nov; 57(11):3349-56. PubMed ID: 2807527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
    Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
    East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes.
    Scott P; Caspar P; Sher A
    J Immunol; 1990 Feb; 144(3):1075-9. PubMed ID: 2295814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
    Scott P; Pearce E; Natovitz P; Sher A
    J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins.
    Russo DM; Turco SJ; Burns JM; Reed SG
    J Immunol; 1992 Jan; 148(1):202-7. PubMed ID: 1370169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parasite escape mechanisms: the role of Leishmania lipophosphoglycan on the human phagocyte functions. A review.
    Panaro MA; Panunzio M; Jirillo E; Marangi A; Brandonisio O
    Immunopharmacol Immunotoxicol; 1995 Aug; 17(3):595-605. PubMed ID: 8576549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Leishmania donovani lipophosphoglycan T lymphocyte-reactive component is a tightly associated protein complex.
    Jardim A; Tolson DL; Turco SJ; Pearson TW; Olafson RW
    J Immunol; 1991 Nov; 147(10):3538-44. PubMed ID: 1940354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between Leishmania parasites and host cells.
    Brandonisio O; Panaro MA; Sisto M; Acquafredda A; Fumarola L; Leogrande D
    Parassitologia; 2000 Dec; 42(3-4):183-90. PubMed ID: 11686076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major.
    Doherty TM; Coffman RL
    J Immunol; 1993 Jun; 150(12):5476-83. PubMed ID: 8515072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological and biochemical analysis of glycosylated surface antigens and lipophosphoglycan of Tritrichomonas foetus.
    Singh BN; BonDurant RH; Campero CM; Corbeil LB
    J Parasitol; 2001 Aug; 87(4):770-7. PubMed ID: 11534640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
    Liew FY; Dhaliwal JS
    J Immunol; 1987 Jun; 138(12):4450-6. PubMed ID: 3295049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania lipophosphoglycan activates the transcription factor activating protein 1 in J774A.1 macrophages through the extracellular signal-related kinase (ERK) and p38 mitogen-activated protein kinase.
    Balaraman S; Singh VK; Tewary P; Madhubala R
    Mol Biochem Parasitol; 2005 Jan; 139(1):117-27. PubMed ID: 15610826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease.
    Lira R; Méndez S; Carrera L; Jaffe C; Neva F; Sacks D
    Exp Parasitol; 1998 Jul; 89(3):331-42. PubMed ID: 9676711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a macrophage-binding determinant on lipophosphoglycan from Leishmania major promastigotes.
    Kelleher M; Bacic A; Handman E
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):6-10. PubMed ID: 1370357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemical characterization of a glyco-inositol-phospholipid membrane antigen of Leishmania major.
    Elhay MJ; McConville MJ; Handman E
    J Immunol; 1988 Aug; 141(4):1326-31. PubMed ID: 3397542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania major: Reactive oxygen species and interferon gamma induction by soluble lipophosphoglycan of stationary phase promastigotes.
    Kavoosi G; Ardestani SK; Kariminia A; Abolhassani M; Turco SJ
    Exp Parasitol; 2006 Dec; 114(4):323-8. PubMed ID: 16759653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive transfer of Leishmania lipopolysaccharide confers parasite survival in macrophages.
    Handman E; Schnur LF; Spithill TW; Mitchell GF
    J Immunol; 1986 Dec; 137(11):3608-13. PubMed ID: 3782793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major.
    Späth GF; Epstein L; Leader B; Singer SM; Avila HA; Turco SJ; Beverley SM
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9258-63. PubMed ID: 10908670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of human T lymphocytes by Leishmania lipophosphoglycan.
    Kemp M; Theander TG; Handman E; Hey AS; Kurtzhals JA; Hviid L; Sørensen AL; Were JO; Koech DK; Kharazmi A
    Scand J Immunol; 1991 Feb; 33(2):219-24. PubMed ID: 1902000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.